Outcomes of Patients with Primary Mediastinal B-Cell Lymphoma Treated with Dose Adjusted R-EPOCH Regimen: A Single Centre Experience | Zendy

Hasmukh Jain | Zendy; Akhil Kapoor | Zendy; Manju Sengar | Zendy; Raajit Chanana | Zendy; Hari Me | Zendy; Sridhar Epari | Zendy; Siddhartha Laskar | Zendy; Archi Agarwal | Zendy; J. Shastri | Zendy; Nehal Khanna | Zendy; Venkatesh Rangarajan | Zendy; Bhausaheb Bagal | Zendy; Jayashree Thorat | Zendy; Tanuja Shet | Zendy; Sumeet Gujral | Zendy

Open Access

Outcomes of Patients with Primary Mediastinal B-Cell Lymphoma Treated with Dose Adjusted R-EPOCH Regimen: A Single Centre Experience

Author(s) -

Hasmukh Jain,

Akhil Kapoor,

Manju Sengar,

Raajit Chanana,

Hari Me,

Sridhar Epari,

Siddhartha Laskar,

Archi Agarwal,

J. Shastri,

Nehal Khanna,

Venkatesh Rangarajan,

Bhausaheb Bagal,

Jayashree Thorat,

Tanuja Shet,

Sumeet Gujral

Publication year - 2021

Publication title -

indian journal of hematology and blood transfusion/indian journal of hematology and blood transfusion

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.213

H-Index - 15

eISSN - 0974-0449

pISSN - 0971-4502

DOI - 10.1007/s12288-020-01372-y

Subject(s) - medicine , regimen , epoch (astronomy) , adverse effect , surgery , neutropenia , single center , lymphoma , retrospective cohort study , febrile neutropenia , chemotherapy , stars , physics , astronomy

Primary Mediastinal B cell lymphoma (PMBCL) is a biologically and clinically distinct subset of diffuse large B cell lymphoma. We analysed the outcomes of our cohort of PMBCL patients treated with Dose adjusted (DA)-R-EPOCH regimen.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Empowering knowledge with every search

About

About Careers Publisher Partners Contact Us

Learn

FAQs Blog Terms of Use Privacy Policy

About

Learn

Discover

Explore